efficaci safeti short-term intraven infus dopexamin patient sever congest heart failur random double-blind parallel placebo-control multicent studi dopexamin hydrochlorid new synthet catechol uniqu profil adrenerg dopaminerg activ multicent parallel design placebo-control studi patient function class iii IV chronic congest heart failur placebo infus differ dose dopexamin dose titrat sequenc patient constant dose infus period dopexamin rate micrograms/kg bodi min low intermedi high dose group patient high dose infus dopexamin increas cardiac index decreas system vascular resist increas heart rate placebo variabl trend NS moder increas cardiac index low intermedi dose patient dopexamin right atrial system arteri pulmonari arteri pulmonari capillari wedg pressur minim chang baselin placebo respons patient advers reaction patient high dose patient intermedi dose dopexamin dose reduct hemodynam variabl arbitrari safeti limit patient symptom studi medic dopexamin dose cardiac index associ reduct system vascular resist addit clinic studi merit dopexamin comparison inotrop vasodil medic 